Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP
Consultant Physician
MBBS, MRCP (UK), FCPS (Pak), FCCP, FRCPE, M.B.B.S.
Consultant Physician
MBBS, MRCP (UK), FCPS (Pak), FCCP, FRCPE, M.B.B.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), M.R.C.P. (Uk), F.R.C.P. (London)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), M.R.C.P. (Uk), F.R.C.P. (London)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S., Diploma in Diabetology, M.C.P.S (Family Medicine)
Internal Medicine Specialist
M.B.B.S., Diploma in Diabetology, M.C.P.S (Family Medicine)
Diabetologist
MBBS, FCPS (Medicine), MRCP (Medicine)
Internal Medicine Specialist
MBBS, FCPS Medicine
Internal Medicine Specialist
M.B.B.S., M.C.P.S
Pulmonologist
MBBS, MRCP, FRACP, M.P.H., FACP (USA), FCCP (USA)
Internal Medicine Specialist
MBBS, European Board Certified (Emergency Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures